U.S. RESEARCH ROUNDUP-B&G Foods, General Motors Co, Point Biopharma Global

Hub

04/10/2023 08:16

Oct 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies, including B&G Foods, General Motors Co and Point Biopharma Global on Wednesday. 
    
    HIGHLIGHTS
                 * B&G Foods Inc  BGS.N : Piper Sandler cuts to underweight from neutral 
 
                 * General Motors Co  GM.N : CFRA raises to sell from strong sell 
 
                 * Point Biopharma Global Inc  PNT.O : Truist Securities cuts to hold from buy 
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical
order. 
    
                 * B&G Foods Inc  BGS.N : Piper Sandler cuts target price to $8 from $14 
 
                 * B&G Foods Inc  BGS.N : Piper Sandler cuts to underweight from neutral 
 
                 * Chuy's Holdings Inc  CHUY.O : Stifel cuts target price to $36 from $40 
 
                 * Ebix Inc  EBIX.O : Craig-Hallum cuts target price to $20 
 
                 * Enhabit Inc  EHAB.N : Leerink Partners cuts target price to $7 from $8 
 
                 * General Motors Co  GM.N : CFRA raises to sell from strong sell 
 
                 * Hub Group Inc  HUBG.O : Stephens cuts target price to $86 from $91 
 
                 * Kenvue Inc  KVUE.N : JP Morgan cuts target price to $26 from $29 
 
                 * Point Biopharma Global Inc  PNT.O : Jonestrading cuts to hold rating 
 
                 * Point Biopharma Global Inc  PNT.O : Truist Securities cuts target price to $12.5 from $13 
 
                 * Point Biopharma Global Inc  PNT.O : Truist Securities cuts to hold from buy 
 
                 * Trinity Industries Inc  TRN.N : Stephens cuts target price to $27 from $28 
 
                 * Vestis Corp  VSTS.N : Baird initiates coverage with outperform rating; target price $24 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))